Jorge Gamonal

Jorge Gamonal

Auto-generated profile, based on publicly available information

Jorge Gamonal

Center for Epidemiology and Surveillance of Oral Diseases (CESOD), Faculty of Dentistry, University of Chile, Santiago 7530263, Región Metropolitana, Chile

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
NSNora Silva
Nora Silva
LALoreto Abusleme
Loreto Abusleme
DBDenisse Bravo
Denisse Bravo
NDNicolás Dutzan
Nicolás Dutzan
JGJocelyn Garcia-Sesnich
Jocelyn Garcia-Sesnich
JGJorge Gamonal
Jorge Gamonal
Periodontal diseases usually refer to common inflammatory disorders known as gingivitis and periodontitis, which are caused by a pathogenic microbiota in the subgingival biofilm, including Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Tannerella forsythia and Treponema denticola that trigger innate, inflammatory, and adaptive immune responses. These processes result in the destruction of the tissues surrounding and supporting the teeth, and eventually in tissue, bone and finally, tooth loss. The innate immune response constitutes a homeostatic system, which is the first line of defense, and is able to recognize invading microorganisms as non-self, triggering immune responses to eliminate them. In addition to the innate immunity, adaptive immunity cells and characteristic cytokines have been described as important players in the periodontal disease pathogenesis scenario, with a special attention to CD4+ T-cells (T-helper cells). Interestingly, the T cell-mediated adaptive immunity development is highly dependent on innate immunity-associated antigen presenting cells, which after antigen capture undergo into a maturation process and migrate towards the lymph nodes, where they produce distinct patterns of cytokines that will contribute to the subsequent polarization and activation of specific T CD4+ lymphocytes. Skeletal homeostasis depends on a dynamic balance between the activities of the bone-forming osteoblasts (OBLs) and bone-resorbing osteoclasts (OCLs). This balance is tightly controlled by various regulatory systems, such as the endocrine system, and is influenced by the immune system, an osteoimmunological regulation depending on lymphocyte- and macrophage-derived cytokines. All these cytokines and inflammatory mediators are capable of acting alone or in concert, to stimulate periodontal breakdown and collagen destruction via tissue-derived matrix metalloproteinases, a characterization of the progression of periodontitis as a stage that presents a significantly host immune and inflammatory response to the microbial challenge that determine of susceptibility to develop the destructive/progressive periodontitis under the influence of multiple behavioral, environmental and genetic factors.

1 January 2020 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
MBMauricio Baeza
Mauricio Baeza
AMAlicia Morales
Alicia Morales
CCCarlos Cisterna
Carlos Cisterna
FCFranco Cavalla
Franco Cavalla
GJGisela Jara
Gisela Jara
JGJorge Gamonal
Jorge Gamonal
The evidence is inconclusive regarding the effect of periodontal treatment on glycemic control and systemic inflammation in patients with type 2 diabetes (T2D) and periodontitis. To evaluate the effect of scaling and root planing (SRP) on the metabolic control and systemic inflammation of patients with type 2 diabetes (T2D). A literature search was conducted using the MEDLINE database via PubMed and the Cochrane Central Register of Controlled Trials, from their oldest records up to July 2018. Only randomized clinical trials (RCT) were considered eligible for evaluating the effect of periodontal treatment on markers of metabolic control [glycated hemoglobin (HbA1C)] and systemic inflammation [C-reactive protein (CRP)] in patients with T2D. The quality of the studies was evaluated using the Cochrane Collaboration risk assessment tool. Meta-analyses were performed for HbA1c and CRP using random effects models. The size of the overall intervention effect was estimated by calculating the weighted average of the differences in means (DM) between the groups in each study. Heterogeneity was assessed using the Q-statistic method (x2 and I²). The level of significance was established at p0.05). SRP has an impact on metabolic control and reduction of systemic inflammation of patients with T2D.

6 April 2011 in Journal of Dental Research
Verified
Journal Article
Closed access
Marcela HernándezMarcela Hernández
Marcela Hernández
NDN. Dutzan
N. Dutzan
JGJ. García-Sesnich
J. García-Sesnich
LAL. Abusleme
L. Abusleme
ADA. Dezerega
A. Dezerega
JGJ. Gamonal
J. Gamonal
Periodontitis is an infection characterized by the occurrence of supporting tissue destruction with an episodic nature. Disease progression is often determined by the loss of attachment level or alveolar bone, and sequential probing of periodontal attachment remains the most commonly utilized method to diagnose progressive destruction of the periodontium. The tolerance method has been the most extensive clinical method used in recent years to determine site-specific attachment level changes. There is abundant evidence that major tissue destruction in periodontal lesions results from the recruitment of immune cells. Considerable effort has been made to study the host cell and mediator profiles involved in the pathogenesis of chronic periodontitis, but the definition of active sites, where current periodontal breakdown occurs, and consecutive characterization of the mediators involved are still among the main concerns. In the present review, we summarize periodontopathic bacteria and host factors, including infiltrating cell populations, cytokines, and host matrix metalloproteinases, associated with under-going episodic attachment loss that could partly explain the mechanisms involved in destruction of the supporting tissues of the tooth.

4 February 2008 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
NSNora Silva
Nora Silva
NDNicolas Dutzan
Nicolas Dutzan
Marcela HernándezMarcela Hernández
Marcela Hernández
ADAndrea Dezerega
Andrea Dezerega
OROriana Rivera
Oriana Rivera
JGJorge Gamonal
Jorge Gamonal

1 August 2016 in Journal of Periodontology
Verified
Journal Article
Closed access
AMAlicia Morales
Alicia Morales
PCPaola Carvajal
Paola Carvajal
NSNora Silva
Nora Silva
Marcela HernándezMarcela Hernández
Marcela Hernández
CGClaudia Godoy
Claudia Godoy
JGJorge Gamonal
Jorge Gamonal
Background: Probiotics are living microorganisms that provide beneficial effects for the host when administered in proper quantities. The aim of this double‐masked placebo‐controlled parallel‐arm randomized clinical trial is to evaluate the clinical effects of a Lactobacillus rhamnosus SP1‐containing probiotic sachet as an adjunct to non‐surgical therapy.Methods: Twenty‐eight systemically healthy volunteers with chronic periodontitis were recruited and monitored clinically at baseline and 3, 6, 9, and 12 months after therapy. Clinical parameters measured included plaque accumulation, bleeding on probing, probing depths (PDs), and clinical attachment loss. Patients received non‐surgical therapy, including scaling and root planing (SRP), and were assigned randomly to a test (SRP + probiotic, n = 14) or control (SRP + placebo, n = 14) group. The intake, once a day for 3 months, of an L. rhamnosus SP1 probiotic sachet commenced after the last session of SRP.Results: Both test and control groups showed improvements in clinical parameters at all time points evaluated. However, the test group showed greater reductions in PD than the control. Also, at initial visits and after 1‐year follow‐up, the test group showed a statistically significant reduction in the number of participants with PD ≥6 mm, indicating a reduced need for surgery, in contrast to the placebo group.Conclusion: The results of this trial indicate that oral administration of L. rhamnosus SP1 resulted in similar clinical improvements compared with SRP alone.

1 November 2006 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
Marcela HernándezMarcela Hernández
Marcela Hernández
MVMaria Antonieta Valenzuela
Maria Antonieta Valenzuela
CLCarlos Lopez‐Otin
Carlos Lopez‐Otin
JAJesús Alvarez
Jesús Alvarez
JLJose Manuel Lopez
Jose Manuel Lopez
JGJorge Gamonal
Jorge Gamonal
Background: Matrix metalloproteinases (MMPs) participate in extracellular matrix degradation in physiological and pathological conditions. The available evidence suggests that MMP‐13 plays a significant role in both the initiation and progress of bone resorption. The aim of our study was to identify the presence of MMP‐13 in adult patients with untreated chronic periodontitis. We also determined the activity of MMP‐13 present in lesions undergoing episodic attachment loss in gingival crevicular fluid (GCF) samples.Methods: After monitoring at 2 and 4 months, 21 patients showed destructive periodontitis (periodontally affected sites presenting at least two sites with ≥2 mm clinical attachment loss), and GCF samples were collected both from active and inactive sites (21 GCF samples, each). GCF was collected during a 30‐second interval using a paper strip, and an immunofluorescence assay was performed to determine the basal activity of MMP‐13 and the relationship between 4‐aminophenylmercuric acetate (APMA)‐activated total MMP‐13 and basal MMP‐13 activity. Gingival tissues from five patients were fixed in formalin and MMP‐13 expression was demonstrated using immunohistochemistry and in situ hybridization. MMP‐13 molecular forms were examined by Western immunoblotting with monoclonal antibodies.Results: MMP‐13 was found in 100% of GCF samples from patients with chronic periodontitis. Active sites, associated with tissue destruction, had significantly higher proportions of active MMP‐13 and MMP‐13 activity levels than their inactive counterparts (1.49 versus 1.17 ng fluorescent product, respectively; P <0.05). Western blot, immunohistochemical staining, and in situ hybridization confirmed the presence of MMP‐13 in periodontal disease, with observable differences between periodontitis and healthy subjects. MMP‐13 immunoreactivities were seen mainly as 55 and 48 kDa, corresponding to partially and fully activated forms, respectively, and a smaller proportion of 60‐kDa proenzyme form.Conclusion: MMP‐13 activity in GCF samples was significantly increased in active sites from progressive periodontal disease, supporting its role in the alveolar bone loss developed in this disease.